Contract awardedPCR and molecular diagnostic platforms

Chemagic 360 service plan for Cambridge University Hospitals, from Revvity

Cambridge University Hospitals NHS Foundation Trust bought a year of service cover from Revvity for two Chemagic 360 instruments in its genetics work.

The Chemagic 360 is used to extract nucleic acids. The cover comes under the Signature Plus Service plan and takes in both machines.

The £20,130 contract was awarded in September 2026 and runs to September 2027.

Alert me to similar tenders

Contract ends September 2027

What
PCR and molecular diagnostic platforms
Supplier
Revvity
Value
£20,130
How it was bought
Below threshold - unknown
Dates and next
Sep 2026 to Sep 2027
Being re-tendered now
Open

Being re-tendered now

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays · £270,000 · closes 16 Dec 2026

See the live tender

How it was bought

1 official notice
  1. 16 Sep 2026Award noticeFind a Tender
  2. 16 Sep 2026Contract starts
  3. 16 Dec 2026Re-tender openBids dueLive tender
  4. 15 Sep 2027Contract ends

Cambridge University Hospitals NHS Foundation Trust has bought this 12 or more times since 2021

Last bought
Sep 2026
Typical length
7 months
Typical value
£21,446
Suppliers used
9
in its last 12 purchases
AwardedContractWon byValue
Sep 2026This purchase1 yearRevvity£20,130
Aug 2026Locked1 yearLocked£816,150
Aug 2026Locked3 monthsLocked£22,762
Aug 2026Locked1 yearLocked£20,130
Jun 2026Locked3 monthsLocked£13,642

and at least 7 more

Suppliers Cambridge University Hospitals NHS Foundation Trust has used in its last 12 purchases

SupplierContractsValue
Revvity Won this one3£302,966
Locked2£28,995
Locked1£816,150
Locked1£467,760
Locked1£150,000

and 4 more

See the contracts and who won them

Figures to 21 November 2026

How it compares

With every PCR and molecular diagnostic platforms award since 2021

Half of awards fall between £32,886 and £403,658Median £97,406

Awards
496
Firms that won them
82
Median award
£97,406
of 488 with a value
This award
Smaller than 88%
of them
Typical length
1 year
In East of England
40 awards

Revvity ranks 11th of 82 firms for PCR and molecular diagnostic platforms awards since 2021.

RankFirmAwardsValue
1Locked103£31.8m
2Locked50£13.5m
3Locked45£97m
4Locked33£1.94m
5Locked24£105.1m
5Locked24£1.41m
11Revvity Won this one9£1.73m
See who wins this work

PCR and molecular diagnostic platforms at other buyers

Cambridge University Hospitals NHS Foundation Trust has awarded 803 contracts since 2021.

See Cambridge University Hospitals NHS Foundation Trust's page
  • Revvity has won 72 public contracts since 2021, 5 of them from Cambridge University Hospitals NHS Foundation Trust.

    See everything Revvity has won
    • Sep 2026This purchase£20,130
    • Aug 2026Locked£20,130
    • Jan 2026Locked£262,706
    • Jul 2025Locked£14,974
    • Jun 2025Locked£14,975
    See the contracts

2 PCR and molecular diagnostic platforms tenders are open now

See them
More PCR and molecular diagnostic platforms contracts awarded in 2026